Bristol-Myers Squibb Co
(XSWX:BMY)
CHF
44.39
0 (0%)
Market Cap: 132.71 Bil
Enterprise Value: 175.30 Bil
PE Ratio: 0
PB Ratio: 5.06
GF Score: 76/100 - Q1 2024 Bristol-Myers Squibb Co Earnings Call TranscriptApr 25, 2024Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference TranscriptMar 14, 2024
- Bristol-Myers Squibb Co at Leerink Partners Global Biopharma Conference TranscriptMar 13, 2024
- Bristol-Myers Squibb Co at TD Cowen Health Care Conference TranscriptMar 04, 2024
- Q4 2023 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 02, 2024Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Bristol-Myers Squibb Co to Acquire Karuna Therapeutics Inc-M&A Call TranscriptDec 22, 2023
- Bristol-Myers Squibb Co at Jefferies London Healthcare Conference TranscriptNov 16, 2023
- Bristol-Myers Squibb Co at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Bristol-Myers Squibb Co Earnings Call TranscriptOct 26, 2023Earnings
- Bristol-Myers Squibb Co R&D Day TranscriptSep 14, 2023
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Bristol-Myers Squibb Co Earnings Call TranscriptJul 27, 2023Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Bristol-Myers Squibb Co at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Bristol-Myers Squibb Co Virtual Investor Event: ASCO 2023 TranscriptJun 06, 2023
- Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Bristol-Myers Squibb Co Earnings Call TranscriptApr 27, 2023Earnings
- Bristol-Myers Squibb Co at Cowen Health Care Conference TranscriptMar 07, 2023
- Bristol-Myers Squibb Co at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 09, 2023
- Q4 2022 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 02, 2023Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Bristol-Myers Squibb Co Earnings Call TranscriptOct 26, 2022Earnings
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Bristol-Myers Squibb Co at Citi BioPharma Conference TranscriptSep 08, 2022
- Bristol-Myers Squibb Co Investor Event TranscriptAug 28, 2022
- Q2 2022 Bristol-Myers Squibb Co Earnings Call TranscriptJul 27, 2022Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Bristol-Myers Squibb Co at Sanford C Bernstein Strategic Decisions Conference TranscriptJun 02, 2022
- Bristol-Myers Squibb Co at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Bristol-Myers Squibb Co Earnings Call TranscriptApr 29, 2022Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference - Fireside Chat TranscriptMar 16, 2022
- Bristol-Myers Squibb Co at Guggenheim Healthcare Talks: Targeted Protein Degradation Day (Virtual) - Fireside Chat TranscriptMar 16, 2022
- Q4 2021 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 04, 2022Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 17, 2021
- Bristol-Myers Squibb Co Investor Event TranscriptNov 16, 2021
- Q3 2021 Bristol-Myers Squibb Co Earnings Call TranscriptOct 27, 2021Earnings
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 Bristol-Myers Squibb Co Earnings Call TranscriptJul 28, 2021Earnings
- Bristol-Myers Squibb Co at William Blair Biotech Focus Conference (Virtual) TranscriptJul 14, 2021
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Bristol-Myers Squibb Co Investor Event to Discuss Data Presented at ASCO TranscriptJun 08, 2021
- Bristol-Myers Squibb Co at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptJun 02, 2021
- Bristol-Myers Squibb Co at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Bristol-Myers Squibb Co at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Bristol-Myers Squibb Co at Truist Securities Life Sciences Summit (May Series) TranscriptMay 05, 2021
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 04, 2021
- Q1 2021 Bristol-Myers Squibb Co Earnings Call TranscriptApr 29, 2021Earnings
- Bristol-Myers Squibb Co Virtual Investor Event to Discuss AAD VMX Highlights TranscriptApr 23, 2021
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Bristol-Myers Squibb Co at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Bristol-Myers Squibb Co at Raymond James Institutional Investors Conference (Virtual) TranscriptMar 02, 2021
- Bristol-Myers Squibb Co at Guggenheim Partners Healthcare Talks Oncology Days TranscriptFeb 12, 2021
- Q4 2020 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 04, 2021CHF44.39Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 18, 2020
- Q3 2020 Bristol-Myers Squibb Co Earnings Call TranscriptNov 05, 2020CHF44.39Earnings
- Bristol-Myers Squibb Co Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia (ozanimod) in Ulcerative Colitis at UEG Week 2020 TranscriptOct 12, 2020
- Bristol-Myers Squibb Company, MyoKardia, Inc. - M&A Call TranscriptOct 05, 2020
- Bristol-Myers Squibb Co Investor Event at European Society of Medical Oncology TranscriptSep 21, 2020
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Bristol-Myers Squibb Co at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2020
- Q2 2020 Bristol-Myers Squibb Co Earnings Call TranscriptAug 06, 2020CHF44.39Earnings
- Bristol-Myers Squibb Co Three-Part Investor Series: Immunology and Cardiovascular TranscriptJun 26, 2020
- Bristol-Myers Squibb Co Three-Part Investor Series: Hematology TranscriptJun 25, 2020
- Bristol-Myers Squibb Co Three-Part Investor Series: Early Pipeline and Immuno-Oncology TranscriptJun 22, 2020
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Bristol-Myers Squibb Co at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- bluebird bio Inc and Bristol-Myers Squibb Co to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Bristol-Myers Squibb Co and bluebird bio Inc to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Q1 2020 Bristol-Myers Squibb Co Earnings Call TranscriptMay 07, 2020CHF44.39Earnings
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 05, 2020
- Q4 2019 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 06, 2020CHF44.39Earnings
- Roche Holding AG, Bristol-Myers Squibb Co and PhRMA at JPMorgan Healthcare Conference - Panel Session TranscriptJan 15, 2020
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top TranscriptJan 09, 2020
- Bristol-Myers Squibb Co to Hold Investor Webcast to Discuss ASH Highlights TranscriptDec 09, 2019
- Bristol-Myers Squibb Co at Wolfe Research Inaugural Healthcare Conference TranscriptNov 06, 2019
- Q3 2019 Bristol-Myers Squibb Co Earnings Call TranscriptOct 31, 2019CHF44.39Earnings
- Bristol-Myers Squibb Co to Discuss ESMO Highlights Call TranscriptSep 28, 2019
- Bristol-Myers Squibb Co at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Bristol-Myers Squibb Co Earnings Call TranscriptJul 25, 2019CHF44.39Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 29, 2019
- Bristol-Myers Squibb Co at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Q1 2019 Bristol-Myers Squibb Co Earnings Call TranscriptApr 25, 2019CHF46.19Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Bristol-Myers Squibb Co at Cowen Health Care Conference TranscriptMar 12, 2019
- Bristol-Myers Squibb Co at Guggenheim Partners Oncology Day TranscriptFeb 14, 2019
- Q4 2018 Bristol-Myers Squibb Co Earnings Call TranscriptJan 24, 2019CHF49.2 (+0.31%)Earnings
Bristol-Myers Squibb Co at Cowen Healthcare Conference (Virtual) Transcript
Mar 03, 2021 / 03:20PM GMT
Release Date Price:
CHF44.39
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good morning, and welcome to the Bristol-Myers Squibb session within the Cowen 41st Annual Healthcare Conference. We're delighted have Bristol with us again this year.
Representing the company is Samit Hirawat, who's Executive Vice President and Chief Medical Officer. There's so many new developments and new products and new initiatives at Bristol that it's a full-time job to keep track of them all. But the best person on the planet to give us an update on all of them is Samit. So Samit, thank you so much for spending this time with us.
Samit Hirawat
Bristol-Myers Squibb Company - Executive VP & Chief Medical Officer of Global Drug Development
Thank you, Steve.
Questions & Answers
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
I'd like to start out by asking, Bristol has numerous -- has had numerous positive clinical trial readouts over the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)